Menu

Recent Interviews

Jerre Foo, Corporate Development Executive, Silkroad Nickel

Jerre Foo
Corporate Development Executive | Silkroad Nickel
50 Armenian Street #03-04, 179938 Singapore (SGP)

enquiries@silkroadnickel.com

+65 6327 8971

Silkroad Nickel: 'The course is set for dynamic profit growth.'


Dr. Thomas Gutschlag, CEO, Deutsche Rohstoff AG

Dr. Thomas Gutschlag
CEO | Deutsche Rohstoff AG
Q7, 24, 68161 Mannheim (D)

info@rohstoff.de

+49 621 490 817 0

Interview Deutsche Rohstoff AG: "We can imagine additional investments in the field of electromobility."


Steve Cope, President, CEO and Director, Silver Viper

Steve Cope
President, CEO and Director | Silver Viper
1055 W Hastings St Suite 1130, V6E 2E9 Vancouver (CAN)

info@silverviperminerals.com

+1-604-687-8566

Interview with Silver Viper: Future price drivers and takeover fantasy


06. October 2020 | 11:02 CET

K+S, ThyssenKrupp, Newlox Gold: Hope for old friends!

  • Investments
Photo credits: pixabay.com

The stock market is continually reinventing itself. Last week, no one wanted to bite the bullet, and prices trended down across the board. Even favourites from the technology corner like Tesla and Apple had to give up at short notice. On Monday, we took a deep breath after Donald Trump once again had enough oxygen. The major stock exchanges increased with a good 1-2% growth, and the Nasdaq even ticked up a bit more. Is the correction over? We don't know, but it's worth taking a look at old acquaintances we haven't had on our radar for some time.

time to read: 3 minutes by André Will-Laudien


 

Author

André Will-Laudien

Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

About the author


K+S - Sale of the American salt division

K+S is close to its goal with the planned sale of its American salt business. According to a report by Bloomberg, the US subsidiary Morton Salt is to be sold to the Kissner Group for about USD 3.0 billion. Informed circles report that the transaction is due to be completed as early as this week.

K+S had bought the Company for around USD 1.7 billion and announced in March that it wanted to sell the division because of the high level of debt. The Kassel-based Company had accumulated this debt by building a potash plant in Canada, which cost billions. In 2012, construction work began on the new potash site in the province of Saskatchewan, in which K+S has again invested EUR 3.0 billion. The Bethune plant was officially opened on May 2, 2017, and has a planned final capacity of just under three million tons per year.

In 2015, a takeover bid by its local rival, the Potash Group, was rejected. Due to high levels of debt and collapsing potash prices, the market value of the K+S share fell by a full 90%. Yesterday, the share price turned around and made up 15% in price alone. The €7 mark was reached again. The resurrection of the traditional German commodity value may have begun.

ThyssenKrupp - The silverware sold, is the recovery coming?

Thyssen is not quite out of the headlines, even after significant balance sheet restructuring. In February, under pressure from its creditors, the steel and industrial group sold its extremely profitable elevator division in its entirety for 17.2 billion euros to a consortium led by financial investors Advent and Cinven and the Essen-based RAG Foundation.

Due to the emergency sale, there is a shortfall of around one billion euros in free cash flow in the liquidity statement for the coming year. "The recent rapid decline in the value of the industrial group's shares now adequately reflects the operating risks," a Morgan Stanley analyst wrote on Monday. After a share price quartering since 2019, the new group structure is now even more vulnerable to stormy weather conditions, as the highly profitable elevator division was previously considered a stabilizer against economic uncertainties.

But in February Corona was not yet on the radar screen. So whether the former steel and technology giant will be back on its feet again is still up in the stars. Yesterday, the Company headed north and reached the EUR 4 mark with a daily gain of almost 11%.

Newlox Gold - Slag heaps and recycling

The third resource company on our list has no accounting or operational problems. On the contrary, Newlox Gold Ventures has set out to revive the environmentally unfriendly, historic gold mining operations in Costa Rica, Central America.

Newlox has settled in the middle of an established mining belt and uses the slag heaps of the past decades for ore extraction. Agreements are in place with all primary local mining cooperatives, covering a total of over 30 mining sites. The company is working with Dr Luis Sobral of the Brazilian Center for Mineral Technology (CETEM) to establish a novel mercury recovery system. The elimination of historical pollution from artisanal mining is a desired side effect.

Newlox plans to operate a mill in the Boston District/Costa Rica with a processing capacity of 150 tons per day at mineralization grades of approximately 15 grams per ton of gold and an expected gold recovery of ~90%. All feedstocks are to be provided by the adjacent partners, and profits will be shared equally between the parties. Full operation in the first half of 2021 will be preceded by development, engineering, construction, and commissioning phases during the remainder of the year. All regulatory concessions have already been granted.

Conclusion: With 94.6 million shares outstanding and a price of 0.10 CAD, the Company is valued at only 5 million EUR; the share price was already at a high of 0.19 CAD. Those who prefer a green coat of paint in their speculative precious metal investments are investing in the environmentally friendly activities of Newlox Gold Ventures. The volatility in this stock is not much higher than the fluctuation of the precious metals themselves. Only a few gold and silver stocks on the price list manage to achieve the attribute of sustainability.


Author

André Will-Laudien

Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

About the author



Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold long or short positions in the aforementioned companies and that there may therefore be a conflict of interest. Apaton Finance GmbH may have a paid contractual relationship with the company, which is reported on in the context of the Apaton Finance GmbH Internet offer as well as in the social media, on partner sites or in e-mail messages. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

20. April 2021 | 09:45 CET | by Stefan Feulner

Varta, Sierra Growth, CureVac - Clear signals!

  • Investments

Sometimes, for various reasons, it takes longer before the positive developments of a Company are absorbed by the market and thus provide for price gains. It is currently similar to the precious metal gold, which is still in the consolidation phase. The facts such as national debt, inflation fears and the ultra-loose monetary policy of the central banks speak another clear language.

Read

20. April 2021 | 07:10 CET | by Carsten Mainitz

BioNTech, SunMirror, Steinhoff - Great News!

  • Investments

Shortly before the finish line, the going gets tough again. Many athletes and those who have to really "bite" in the last few meters before a deadline are probably familiar with this feeling. Everyday life in the Corona pandemic is also becoming more exhausting. Now, with BioNTech's announcement that it will double weekly vaccine dose deliveries to around 5.1 million units from the end of May, there may be a breakthrough in achieving herd immunity in Germany in the next few months. It is not only good news for the Company's shareholders but everyone. Below we present two other companies whose shareholders should be very pleased. Let us surprise you!

Read

15. April 2021 | 07:15 CET | by Stefan Feulner

Alibaba, The Place Holdings, CureVac - Great opportunities lie here!

  • Investments

The German vaccination disaster is going into the next round. After the AstraZeneca vaccine's back and forth and the question of whether only younger people, older people or no one should be vaccinated with the vaccine, the American vaccine manufacturer Johnson & Johnson is now experiencing delivery stoppages. The return to "normality" once again seems to be a long way off. Another question to ask yourself. What will future life in the new normal look like in the hard-pressed inner cities?

Read